https://www.selleckchem.com/pr....oducts/ly3200882.htm
Their color changed from maroon to reddish, suggesting that such molecules were present inside the desiccator.Patients with breast cancer often receive many drugs to manage the cancer, side effects associated with cancer treatment, and co-morbidities (i.e., polypharmacy). Drug-drug and drug-gene interactions contribute to the risk of adverse events (AEs), which could lead to non-adherence and reduced efficacy. Here we investigated several well-characterized inherited (germline) pharmacogenetic (PGx) targets in 225 patients with breast
Like
Comment
Share
